BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 38570856)

  • 1. Circ_0002669 promotes osteosarcoma tumorigenesis through directly binding to MYCBP and sponging miR-889-3p.
    Zhang Y; Zhan Y; Liu Z; Guo H; Liu D; Chen C
    Biol Direct; 2024 Apr; 19(1):25. PubMed ID: 38570856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of hsa_circ_0136666 predicts poor prognosis and initiates osteosarcoma tumorigenesis through miR-593-3p/ZEB2 pathway.
    Zhang C; Zhou H; Yuan K; Xie R; Chen C
    Aging (Albany NY); 2020 May; 12(11):10488-10496. PubMed ID: 32424109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.
    Wu Y; Xie Z; Chen J; Chen J; Ni W; Ma Y; Huang K; Wang G; Wang J; Ma J; Shen S; Fan S
    Mol Cancer; 2019 Apr; 18(1):73. PubMed ID: 30940151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma.
    Deng N; Li L; Gao J; Zhou J; Wang Y; Wang C; Liu Y
    Biochem Biophys Res Commun; 2018 Jan; 495(1):189-196. PubMed ID: 29117539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0001174 facilitates osteosarcoma cell proliferation, migration, and invasion by targeting the miR-186-5p/MACC1 axis.
    Lin F; Wang X; Zhao X; Ren M; Wang Q; Wang J
    J Orthop Surg Res; 2022 Mar; 17(1):159. PubMed ID: 35279159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA hsa_circ_0069117 suppresses proliferation and migration of osteosarcoma cells lines via miR-875-3p/PF4V1 axis.
    Zhang Z; Zhou L; Zhou S; Li X
    J Orthop Surg Res; 2022 Jan; 17(1):37. PubMed ID: 35062989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circDOCK1 contributes to osteosarcoma progression by acting as a ceRNA for miR-936 to regulate LEF1.
    Xu G; Zhang H; Shi Y; Yang F
    J Bone Oncol; 2022 Oct; 36():100453. PubMed ID: 36147545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer.
    Ma S; Wei H; Wang C; Han J; Chen X; Li Y
    Cell Mol Biol Lett; 2021 Dec; 26(1):52. PubMed ID: 34895159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis.
    Li S; Liu F; Zheng K; Wang W; Qiu E; Pei Y; Wang S; Zhang J; Zhang X
    Mol Cancer; 2021 Dec; 20(1):161. PubMed ID: 34876132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-889-3p restrains the proliferation and epithelial-mesenchymal transformation of lung cancer cells via down-regulation of Homeodomain-interacting protein kinase 1.
    Zhu Q; Li Y; Li L; Guo M; Zou C; Xu Y; Yang Z
    Bioengineered; 2021 Dec; 12(2):10945-10958. PubMed ID: 34723781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ_001422 promotes the progression and metastasis of osteosarcoma via the miR-195-5p/FGF2/PI3K/Akt axis.
    Yang B; Li L; Tong G; Zeng Z; Tan J; Su Z; Liu Z; Lin J; Gao W; Chen J; Zeng S; Wu G; Li L; Zhu S; Liu Q; Lin L
    J Exp Clin Cancer Res; 2021 Jul; 40(1):235. PubMed ID: 34271943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation.
    Jia L; Wang Y; Wang CY
    Adv Sci (Weinh); 2021 Jul; 8(13):2003376. PubMed ID: 34258151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference with circRNA DOCK1 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by regulating the miR-654-5p/SMAD2 axis.
    Lu Y; Zhang J; Wu Y
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184075
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.